For example, in the BIOSTAT-CHF trial, analysis of a comprehensive multi-marker profiling panel revealed that biological processes producing or responding to interferon-gamma (IFN-γ) correlate with reduced mortality, whereas processes associated with T-cell activity demonstrate a relationship with increased mortality rates [20]. Here, IFNG is linked to congestive heart failure.